Toggle light / dark theme

Tumors Use Antioxidant Protein to Disarm Cancer-Fighting T Cells

“Here, we show that cancer cells release antioxidant enzymes into the tumor interstitium, creating an antioxidant extracellular environment that is suppressive of T cell activation,” the authors write.

When the researchers analyzed tumor interstitial fluid—the liquid surrounding cells within a tumor—they found potent antioxidant activity and high levels of PRDX1. Adding extracellular PRDX1 to T cells reduced their ROS levels and disrupted T-cell receptor signaling, weakening their ability to mount an immune response.

The team then genetically deleted Prdx1 from cancer cells. Without tumor-derived PRDX1, T cells became more active and antitumor immunity increased. Importantly, eliminating PRDX1 also made tumors more responsive to immunotherapy in experimental models.

Leave a Comment

Lifeboat Foundation respects your privacy! Your email address will not be published.